The first US study on the latest COVID-19 vaccines in development found they are 54 percent effective at preventing symptoms of the disease in adults.
Advertisement
The latest COVID-19 vaccine shots are 54 percent effective in preventing symptomatic infection in adults, according to a recent study by the US Centers for Disease Control and Prevention (CDC).
The latest vaccines, which became available last year, were designed to better protect people against the latest variants of the virus.
In a study released Thursday that included 9,000 people tested for COVID-19 at CVS and Walgreens pharmacies across the U.S., the CDC concluded that in 54 percent of cases, the new shots prevented adults from getting COVID-19. Prevented from getting infected. Virus before developing symptoms.
According to the CDC’s Ruth Link-Giles, lead author of the study, the study’s findings are similar to results seen in other countries and results obtained by previous vaccines.
Link-Giles said researchers will need more time to understand whether the new shots are effective in preventing symptoms severe enough to send patients to a doctor’s office or hospital.
At the end of summer last year, the CDC recommended that everyone six months and older get the new vaccine, noting a surge in infections was expected especially in the fall and winter when people are traditionally more vulnerable to colds, flu and other common illnesses. Become ill from. Respiratory diseases.
The latest CDC data shows that only 22 percent of American adults have received vaccines and only 11 percent of children. In Europe, vaccination campaigns have varied from country to country, but most have recommended that new vaccines be given to the most vulnerable first, including the elderly and those with weakened immune systems.
According to the latest report on vaccination released by the European Center for Disease Prevention and Control (ECDC) on January 26, about 19.4 million people aged 60 and above received a dose of a COVID-19 vaccine between September 2023 and January 2024.
About 5.5 million people aged 80 and older received a COVID-19 vaccine dose during the same period.
According to the ECDC, the average COVID-19 vaccination coverage among people aged 60 and older in Europe was 11.1 percent, with high variation between countries. For people aged 80 and older, average coverage was slightly higher at 16.3 percent, with high variation between countries.
Source
